New drug tested to protect transplanted livers
Disease control
Recruiting now
This early-stage study is testing the safety of an investigational drug called siplizumab in patients with autoimmune liver disease who are receiving a liver transplant. The drug is given right after surgery to help prevent the body's immune system from attacking the new liver. U…
Phase: PHASE1 • Sponsor: Elizabeth C. Verna • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC